Filtros de búsqueda

Lista de obras de Taina Turpeenniemi-Hujanen

2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

artículo científico publicado en 2013

A prognostic index in skin melanoma through the combination of matrix metalloproteinase-2, Ki67, and p53

artículo científico publicado el 21 de febrero de 2011

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

artículo científico publicado en 2006

Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma

artículo científico publicado en 2015

Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

artículo científico publicado en 2005

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.

artículo científico publicado en 2016

Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study

artículo científico publicado en 2011

Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure

artículo científico publicado en 2013

Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma

artículo científico publicado en 2013

Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma

artículo científico publicado en 2008

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

artículo científico publicado en 2015

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

artículo científico publicado en 2011

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

artículo científico publicado en 2009

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial

scientific article published on 01 September 2018

Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial

artículo científico publicado en 2009

Generalisability of survival estimates for patients with breast cancer – A comparison across two population-based series

article

Long-term prognosis of breast cancer detected by mammography screening or other methods

artículo científico publicado en 2011

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

artículo científico publicado en 2008

Promising treatment results with blood brain barrier disruption (BBBD) based immunochemotherapy combined with autologous stem cell transplantation (ASCT) in patients with primary central nervous system lymphoma (PCNSL).

artículo científico publicado en 2016

Snail promotes an invasive phenotype in lung carcinoma

artículo científico publicado en 2012

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study

artículo científico publicado el 22 de abril de 2011

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

artículo científico publicado en 2016

Very high quantitative tumor HER2 content and outcome in early breast cancer

scientific article published on 01 February 2011

p53 in head and neck cancer: Functional consequences and environmental implications of TP53mutations

artículo científico publicado el 15 de diciembre de 2010